G

Gentian Diagnostics ASA
OSE:GENT

Watchlist Manager
Gentian Diagnostics ASA
OSE:GENT
Watchlist
Price: 55.6 NOK -0.71%
Market Cap: 857.4m NOK

Intrinsic Value

The intrinsic value of one GENT stock under the Base Case scenario is 45.72 NOK. Compared to the current market price of 55.6 NOK, Gentian Diagnostics ASA is Overvalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GENT Intrinsic Value
45.72 NOK
Overvaluation 18%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation History
Gentian Diagnostics ASA

What is Valuation History?
Ask AI Assistant
What other research platforms think about GENT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is GENT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Gentian Diagnostics ASA.

Explain Valuation
Compare GENT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GENT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Gentian Diagnostics ASA

Current Assets 167.4m
Cash & Short-Term Investments 80.2m
Receivables 35.5m
Other Current Assets 51.7m
Non-Current Assets 63.8m
PP&E 11m
Intangibles 31.5m
Other Non-Current Assets 21.3m
Current Liabilities 30.6m
Other Current Liabilities 30.6m
Non-Current Liabilities 3.2m
Long-Term Debt 3.2m
Efficiency

Free Cash Flow Analysis
Gentian Diagnostics ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Gentian Diagnostics ASA

Revenue
163.4m NOK
Cost of Revenue
-74.8m NOK
Gross Profit
88.5m NOK
Operating Expenses
-68.8m NOK
Operating Income
19.8m NOK
Other Expenses
22.4m NOK
Net Income
42.2m NOK
Fundamental Scores

GENT Profitability Score
Profitability Due Diligence

Gentian Diagnostics ASA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

56/100
Profitability
Score

Gentian Diagnostics ASA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

GENT Solvency Score
Solvency Due Diligence

Gentian Diagnostics ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Gentian Diagnostics ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GENT Price Targets Summary
Gentian Diagnostics ASA

Wall Street analysts forecast GENT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GENT is 68.34 NOK with a low forecast of 67.67 NOK and a high forecast of 70.35 NOK.

Lowest
Price Target
67.67 NOK
22% Upside
Average
Price Target
68.34 NOK
23% Upside
Highest
Price Target
70.35 NOK
27% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GENT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one GENT stock?

The intrinsic value of one GENT stock under the Base Case scenario is 45.72 NOK.

Is GENT stock undervalued or overvalued?

Compared to the current market price of 55.6 NOK, Gentian Diagnostics ASA is Overvalued by 18%.

Back to Top